Hirofumi Satake

623 total citations
17 papers, 529 citations indexed

About

Hirofumi Satake is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Hirofumi Satake has authored 17 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Hirofumi Satake's work include Renal cell carcinoma treatment (3 papers), Prostate Cancer Treatment and Research (3 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Hirofumi Satake is often cited by papers focused on Renal cell carcinoma treatment (3 papers), Prostate Cancer Treatment and Research (3 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Hirofumi Satake collaborates with scholars based in Japan, Indonesia and United States. Hirofumi Satake's co-authors include K Nakano, Tetsuhiko Shirasaka, Junji Uchida, A Fujioka, Setsuo Takeda, Hitoshi Saitô, Hiromi Okabe, M Fukushima, Norio Unemi and Taro Shuin and has published in prestigious journals such as Cancer Research, The Journal of Urology and Annals of Oncology.

In The Last Decade

Hirofumi Satake

15 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hirofumi Satake Japan 7 330 300 130 100 65 17 529
K Nakano Japan 4 347 1.1× 264 0.9× 92 0.7× 93 0.9× 38 0.6× 9 460
A Fujioka Japan 7 506 1.5× 344 1.1× 170 1.3× 130 1.3× 80 1.2× 16 680
Kouichiro Tsugawa Japan 10 196 0.6× 173 0.6× 94 0.7× 214 2.1× 59 0.9× 19 476
Ken Hatogai Japan 13 236 0.7× 288 1.0× 78 0.6× 240 2.4× 38 0.6× 36 546
Yuzhi Lu China 5 290 0.9× 155 0.5× 175 1.3× 100 1.0× 45 0.7× 8 493
Guoqiang Wang China 9 455 1.4× 227 0.8× 89 0.7× 62 0.6× 88 1.4× 24 561
Jean‐Marie Vandenbulcke Belgium 6 310 0.9× 216 0.7× 138 1.1× 172 1.7× 28 0.4× 9 502
Manoj Shah India 11 163 0.5× 112 0.4× 121 0.9× 79 0.8× 65 1.0× 29 346
Mariachiara Santorsola Italy 13 218 0.7× 92 0.3× 121 0.9× 85 0.8× 87 1.3× 45 428
David D. Gibbs New Zealand 8 213 0.6× 173 0.6× 198 1.5× 60 0.6× 58 0.9× 15 514

Countries citing papers authored by Hirofumi Satake

Since Specialization
Citations

This map shows the geographic impact of Hirofumi Satake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Satake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Satake more than expected).

Fields of papers citing papers by Hirofumi Satake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirofumi Satake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Satake. The network helps show where Hirofumi Satake may publish in the future.

Co-authorship network of co-authors of Hirofumi Satake

This figure shows the co-authorship network connecting the top 25 collaborators of Hirofumi Satake. A scholar is included among the top collaborators of Hirofumi Satake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirofumi Satake. Hirofumi Satake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Satake, Hirofumi, Shogen Boku, Seiichiro Mitani, et al.. (2024). 10P A placebo-controlled study comparing doses and efficacy of lentinula edodes mycelia for chemotherapy-induced peripheral neuropathy in colorectal cancer: The LEMON trial. Annals of Oncology. 35. S6–S7. 1 indexed citations
2.
Tamura, Kenji, Nobutaka Shimizu, Hideo Fukuhara, et al.. (2023). Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume. Research and Reports in Urology. Volume 15. 157–164. 2 indexed citations
3.
4.
Karashima, Takashi, Naoto Kuroda, Hirofumi Satake, et al.. (2018). Bilateral Xp11.2 translocation renal cell carcinoma: a case report. BMC Urology. 18(1). 106–106. 6 indexed citations
5.
Tamura, Kenji, Mutsuo Furihata, Hirofumi Satake, et al.. (2017). SHISA2 enhances the aggressive phenotype in prostate cancer through the regulation of WNT5A expression. Oncology Letters. 14(6). 6650–6658. 10 indexed citations
6.
Karashima, Takashi, Hideo Fukuhara, Satoshi Fukata, et al.. (2014). [Clinical study on patients with renal-cell carcinoma accompanied with Von Hippel-Lindau disease treated with radiofrequency ablation].. PubMed. 60(9). 415–20. 2 indexed citations
7.
Tamura, Kenji, Mutsuo Furihata, Hirofumi Satake, et al.. (2012). Abstract 1849: Identification and functional analysis of SHISA2 overexpressed in prostate cancer. Cancer Research. 72(8_Supplement). 1849–1849. 2 indexed citations
8.
Fukuhara, Hideo, Keiji Inoue, Hirofumi Satake, et al.. (2011). Photodynamic diagnosis of positive margin during radical prostatectomy: Preliminary experience with 5‐aminolevulinic acid. International Journal of Urology. 18(8). 585–591. 32 indexed citations
9.
Tamura, Kenji, Mutsuo Furihata, Hirofumi Satake, et al.. (2011). SNRPE is involved in cell proliferation and progression of high-grade prostate cancer through the regulation of androgen receptor expression. Oncology Letters. 3(2). 264–268. 20 indexed citations
10.
Tamura, Kenji, Keiji Inoue, Hirofumi Satake, et al.. (2009). [Experience in the treatment of eight cases of Fournier's gangrene].. PubMed. 55(9). 545–9. 1 indexed citations
11.
Kuroda, Naoto, Hirofumi Satake, Eriko Miyazaki, et al.. (2004). Collecting Duct Carcinoma Exhibiting Diastase-Resistant PAS-Positive Globular Cytoplasmic Inclusions and Rhabdoid Features Arising in Adult Polycystic Kidney Disease: A Case Report. International Journal of Surgical Pathology. 12(2). 171–177. 10 indexed citations
12.
Satake, Hirofumi, Keiji Inoue, Masayuki Kamada, et al.. (2001). MALIGNANT COMPOSITE PHEOCHROMOCYTOMA OF THE ADRENAL GLAND IN A PATIENT WITH VON RECKLINGHAUSEN’S DISEASE. The Journal of Urology. 165(4). 1199–1200. 10 indexed citations
13.
Satake, Hirofumi, Koji Inoue, Katsuhiro Sawada, & Taro Shuin. (2001). [A case of traumatic rupture of the testis: usefulness of magnetic resonance imaging].. PubMed. 47(5). 341–3. 2 indexed citations
14.
Fukushima, M, Hirofumi Satake, Junji Uchida, et al.. (1998). Preclinical antitumor efficacy of S-1: a new oral formulation of 5-fluorouracil on human tumor xenografts.. International Journal of Oncology. 13(4). 693–8. 95 indexed citations
15.
Shirasaka, Tetsuhiko, K Nakano, Hirofumi Satake, et al.. (1996). Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats.. PubMed. 56(11). 2602–6. 335 indexed citations
16.
Ohkubo, Yasuhito, et al.. (1990). The influences of dexamethasone and indomethacine on 67Ga uptake by normal tissues.. RADIOISOTOPES. 39(8). 342–346.
17.
Satake, Hirofumi, et al.. (1986). Anti-parasite activity of nucleoside analogues: the metabolism of carbocyclic inosine in promastigotes of Leishmania tropica and Leishmania donovani and its activity against amastigotes of Leishmania donovani in vitro.. PubMed. 149–51. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K Nakano Breakdown of academic impact, for papers by A Fujioka Breakdown of academic impact, for papers by Kouichiro Tsugawa Breakdown of academic impact, for papers by Ken Hatogai Breakdown of academic impact, for papers by Yuzhi Lu Breakdown of academic impact, for papers by Guoqiang Wang Breakdown of academic impact, for papers by Jean‐Marie Vandenbulcke Breakdown of academic impact, for papers by Manoj Shah Breakdown of academic impact, for papers by Mariachiara Santorsola Breakdown of academic impact, for papers by David D. Gibbs
Rankless by CCL
2026